Company news: GlaxoSmithKline

Share this article:
GlaxoSmithKline is readying another round of R&D cuts and giving its Research Triangle Park workforce a haircut, with plans to eliminate positions at its Neurosciences Medicine Development Center, according to the News & Observer of Raleigh, NC. Less than 50 R&D jobs are being eliminated nationwide, with fewer than half of those coming from Research Triangle Park and Philadelphia emerging largely unscathed. It's a drop in the bucket after years of deep cuts at the company, which has cut 22,000 jobs worldwide between 2007 and 2010, the newspaper reported.
Share this article:

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.